Dyer Mitchell R, Garvey Joseph, Andraska Elizabeth, Brown Joshua B, Eslami Mohammad H, Makaroun Michel S, Chaer Rabih A
Division of Vascular and Endovascular Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.
University of Pittsburgh School of Medicine, Pittsburgh, PA.
J Vasc Surg. 2025 Sep;82(3):867-874.e1. doi: 10.1016/j.jvs.2025.05.007. Epub 2025 May 8.
Blunt cerebrovascular injury (BCVI) refers to blunt, traumatic injury of the carotid or vertebral arteries. Prompt treatment of BCVI is imperative due to the risk of long-term neurologic injuries. Treatment depends in part on injury severity according to the Biffl grade. Despite evidence confirming the safety and accuracy of axial imaging, confirmatory digital subtraction angiography (DSA) is still performed with diagnostic and therapeutic intent. We hypothesized that routine invasive DSA is not indicated for patients with low-grade BCVI for diagnosis or follow-up and is associated with unnecessary costs and complications.
We performed a single-center, restrospective study of the diagnosis and management of patients with BCVI at a Level 1 trauma center. Patients with BCVI were identified by International Classification of Diseases-9/10 codes from the institutional trauma registry from January 1, 2010 to December 31st, 2021. We analyzed the charts of patients with BCVI of the vertebral and carotid arteries and collected demographics, characteristics, and management. Descriptive statistics were performed. Univariate analysis was performed to determine differences between DSA and no-DSA patients. Correlation of noninvasive imaging and DSA results were calculated.
A total of 251 patients with BCVI were diagnosed by computed tomography angiography (CTA) (178 vertebral [71%], 67 [26%] carotid, and 6 [2%] both). Consulted services were neurosurgery (96%), vascular surgery (2%), or both (2%). DSA was performed in 164 patients (43 carotid, 116 vertebral, and 5 both), all performed by neurosurgery; the majority (72%) were done within 24 hours from diagnosis. Most patients (98%) were asymptomatic, with five patients presenting with stroke-like symptoms, and only one of these patients underwent DSA for hemiparesis. Intervention was done in nine patients. All patients were treated with antiplatelets (81%) or anticoagulation (17%). BCVI injury grade correlated between CTA/magnetic resonance angiography and DSA in the majority of patients 88 (79%); was downgraded in 15 patients (13%) where no BCVI was appreciated on DSA; and upgraded in nine patients (8%) for vessel occlusion or pseudoaneurysm formation. No management changes resulted from DSA. DSA-related complications included groin access complications (4.2%) and iatrogenic cerebral artery injury (1.8%). Delayed intervention was required in one patient for a growing pseudoaneurysm noted on noninvasive imaging.
Routine DSA following CTA does not change the management of patients with BCVI. DSA is associated with low but significant rates of complications for diagnosing BCVI. An algorithm that incorporates follow-up noninvasive imaging with duplex ultrasound or CTA may be indicated to identify patients who would benefit from DSA.
钝性脑血管损伤(BCVI)是指颈动脉或椎动脉的钝性创伤性损伤。由于存在长期神经损伤的风险,必须对BCVI进行及时治疗。治疗部分取决于根据比夫尔分级的损伤严重程度。尽管有证据证实轴向成像的安全性和准确性,但仍出于诊断和治疗目的进行确认性数字减影血管造影(DSA)。我们假设,对于低度BCVI患者,常规侵入性DSA对于诊断或随访并无必要,且会带来不必要的费用和并发症。
我们在一家一级创伤中心对BCVI患者的诊断和管理进行了单中心回顾性研究。通过2010年1月1日至2021年12月31日机构创伤登记处的国际疾病分类第9/10版编码识别出BCVI患者。我们分析了椎动脉和颈动脉BCVI患者的病历,并收集了人口统计学、特征和管理情况。进行了描述性统计。进行单因素分析以确定DSA患者和非DSA患者之间的差异。计算了无创成像与DSA结果的相关性。
共有251例BCVI患者通过计算机断层血管造影(CTA)诊断(178例椎动脉损伤[71%],67例[26%]颈动脉损伤,6例[2%]两者均有损伤)。会诊科室为神经外科(96%)、血管外科(2%)或两者(2%)。164例患者进行了DSA(43例颈动脉,116例椎动脉,5例两者均有),均由神经外科进行;大多数(72%)在诊断后24小时内完成。大多数患者(98%)无症状,5例患者出现类似中风的症状,其中只有1例因偏瘫接受了DSA检查。9例患者进行了干预。所有患者均接受抗血小板治疗(81%)或抗凝治疗(17%)。在大多数患者88例(79%)中,CTA/磁共振血管造影与DSA之间的BCVI损伤分级相关;15例患者(13%)的分级降低,这些患者在DSA上未发现BCVI;9例患者(8%)因血管闭塞或假性动脉瘤形成而分级升高。DSA未导致管理方式改变。与DSA相关的并发症包括腹股沟穿刺并发症(4.2%)和医源性脑动脉损伤(1.8%)。1例患者因无创成像发现假性动脉瘤增大而需要延迟干预。
CTA后常规DSA不会改变BCVI患者的管理方式。DSA在诊断BCVI时并发症发生率较低但具有显著性。可能需要一种将双功超声或CTA的随访无创成像纳入的算法,以识别可能从DSA中获益的患者。